EXHIBIT 99.1

 

AGREEMENT REGARDING JOINT FILING

OF STATEMENT ON SCHEDULE 13D OR 13G

 

The undersigned agree to file jointly with the Securities and Exchange Commission (the “SEC”) any and all statements on Schedule 13D or Schedule 13G or Forms 3, 4 or 5(and any amendments or supplements thereto) required under section 13(d) and 16(a) of the Securities Exchange Act of 1934, as amended, in connection with purchases by the undersigned of the securities of any issuer. For that purpose, the undersigned hereby constitute and appoint Beryl Capital Management, LLC, a Delaware limited liability company, as their true and lawful agent and attorney-in-fact, with full power and authority for and on behalf of the undersigned to prepare or cause to be prepared, sign, file with the SEC and furnish to any other person all certificates, instruments, agreements and documents necessary to comply with section 13(d) and section 16(a) of the Securities Exchange Act of 1934, as amended, in connection with said purchases, and to do and perform every act necessary and proper to be done incident to the exercise of the foregoing power, as fully as the undersigned might or could do if personally present.

 

Dated: January 10, 2025

 

BERYL CAPITAL MANAGEMENT LLC  

BERYL CAPITAL MANAGEMENT LP

 

      By: Beryl Capital Management LLC
        General Partner
By: /s/ Andrew Nelson      
  Andrew Nelson     By: /s/ Andrew Nelson
  Chief Operating Officer       Andrew Nelson
        Chief Operating Officer
BERYL CAPITAL PARTNERS II LP    
   
By: Beryl Capital Management LP   /s/ David A. Witkin
General Partner   David A. Witkin
     
By: Beryl Capital Management LLC    
General Partner    
     
By:/s/ Andrew Nelson    
Andrew Nelson    
Chief Operating Officer    
Revance Therapeutics (NASDAQ:RVNC)
Historical Stock Chart
Von Dez 2024 bis Jan 2025 Click Here for more Revance Therapeutics Charts.
Revance Therapeutics (NASDAQ:RVNC)
Historical Stock Chart
Von Jan 2024 bis Jan 2025 Click Here for more Revance Therapeutics Charts.